Creative, efficient, high-powered strategy
We create specific, actionable growth strategies for therapeutics and diagnostics innovators. Our approach is collaborative, cross-disciplinary, customized, and grounded in data and expertise.
Clients
We serve some of the most innovative biotechnology, pharmaceuticals, diagnostics, and medical device companies around the world.
Performance
75%
Projects based on repeat business
97%
Satisfied customers
(since 2017)
$25B
BD/M&A Value
$1.2B
IPO value
$800M +
Private fundraising
These are outcomes that our clients achieved as a result of our collaborative strategy projects.
Services
We empower growth for therapeutics and diagnostics innovators. We set ourselves apart with our hybrid strategy offering (spanning Commercial, R&D, and Corp Dev), our excellent team, our collaborative, bespoke approach, and our diverse, values-driven culture.
01
Commercial Strategy
Helping our clients to
commercialize innovative new products
Corporate Development
02
Growing through business development (BD) and partnering, mergers and acquisitions (M&A), and fundraising
03
Portfolio, R&D Strategy
Creating compelling, specific R&D strategies at the asset and portfolio levels
